Literature DB >> 11917146

In silico identification, structure prediction and phylogenetic analysis of the 2'-O-ribose (cap 1) methyltransferase domain in the large structural protein of ssRNA negative-strand viruses.

Janusz M Bujnicki1, Leszek Rychlewski.   

Abstract

The Escherichia coli RrmJ gene product has recently been shown to be the 23S rRNA:U2552 specific 2'-O-ribose methyltransferase (MTase) (RrmJ). Its structure has been solved and refined to 1.5 A resolution, demonstrating conservation of the three-dimensional fold and key catalytic side chains with the vaccinia virus VP39 protein, which functions as an mRNA 5'm(7)G-cap-N-specific 2'-O-ribose MTase. Using the amino acid sequence of RrmJ as an initial probe in an iterative search of sequence databases, we identified a homologous domain in the sequence of the L protein of non-segmented, negative-sense, single-stranded RNA viruses. The plausibility of the prediction was confirmed by homology modeling and checking whether important residues at substrate/ligand-binding sites were conserved. The predicted structural compatibility and the conservation of the active site between the novel putative MTase domain and genuine 2'-O-ribose MTases, together with the available results of biochemical studies, strongly suggest that this domain is a 5'm(7)G-cap-N-specific 2'-O-ribose MTase (i.e. the cap 1 MTase). Evolutionary relationships between these proteins are also discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11917146     DOI: 10.1093/protein/15.2.101

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  43 in total

Review 1.  An unconventional pathway of mRNA cap formation by vesiculoviruses.

Authors:  Tomoaki Ogino; Amiya K Banerjee
Journal:  Virus Res       Date:  2011-09-16       Impact factor: 3.303

2.  Viruses know more than one way to don a cap.

Authors:  Eugene V Koonin; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-18       Impact factor: 11.205

Review 3.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

4.  Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter.

Authors:  Sarah L Noton; Kartikeya Nagendra; Ewan F Dunn; Michael E Mawhorter; Qin Yu; Rachel Fearns
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

5.  Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.

Authors:  Jing Sun; Yongwei Wei; Abdul Rauf; Yu Zhang; Yuanmei Ma; Xiaodong Zhang; Konstantin Shilo; Qingzhong Yu; Y M Saif; Xingmeng Lu; Lian Yu; Jianrong Li
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

6.  Opposing effects of inhibiting cap addition and cap methylation on polyadenylation during vesicular stomatitis virus mRNA synthesis.

Authors:  Jianrong Li; Amal Rahmeh; Vesna Brusic; Sean P J Whelan
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation.

Authors:  Andrea M Murphy; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

8.  In vitro reconstitution of SARS-coronavirus mRNA cap methylation.

Authors:  Mickaël Bouvet; Claire Debarnot; Isabelle Imbert; Barbara Selisko; Eric J Snijder; Bruno Canard; Etienne Decroly
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

9.  Sequence-function analysis of the Sendai virus L protein domain VI.

Authors:  Andrea M Murphy; Megan Moerdyk-Schauwecker; Arcady Mushegian; Valery Z Grdzelishvili
Journal:  Virology       Date:  2010-07-06       Impact factor: 3.616

10.  Ribose 2'-O methylation of the vesicular stomatitis virus mRNA cap precedes and facilitates subsequent guanine-N-7 methylation by the large polymerase protein.

Authors:  Amal A Rahmeh; Jianrong Li; Philip J Kranzusch; Sean P J Whelan
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.